Free Trial

BATM Advanced Communications (BVC) Competitors

BATM Advanced Communications logo
GBX 13.90 -0.90 (-6.08%)
As of 05/15/2026 12:25 PM Eastern

BVC vs. TSTL, SPEC, AKR, ODX, and CNSL

Should you buy BATM Advanced Communications stock or one of its competitors? MarketBeat compares BATM Advanced Communications with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with BATM Advanced Communications include Tristel (TSTL), INSPECS Group (SPEC), Akers Biosciences (AKR), Omega Diagnostics Group (ODX), and Cambridge Nutritional Sciences (CNSL). These companies are all part of the "medical instruments & supplies" industry.

How does BATM Advanced Communications compare to Tristel?

BATM Advanced Communications (LON:BVC) and Tristel (LON:TSTL) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations.

Tristel has a consensus target price of GBX 400, indicating a potential downside of 1.27%. Given Tristel's higher possible upside, analysts clearly believe Tristel is more favorable than BATM Advanced Communications.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BATM Advanced Communications
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Tristel
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

16.9% of BATM Advanced Communications shares are owned by institutional investors. Comparatively, 22.0% of Tristel shares are owned by institutional investors. 30.4% of BATM Advanced Communications shares are owned by insiders. Comparatively, 21.0% of Tristel shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Tristel had 1 more articles in the media than BATM Advanced Communications. MarketBeat recorded 1 mentions for Tristel and 0 mentions for BATM Advanced Communications. Tristel's average media sentiment score of 0.76 beat BATM Advanced Communications' score of 0.00 indicating that Tristel is being referred to more favorably in the news media.

Company Overall Sentiment
BATM Advanced Communications Neutral
Tristel Positive

BATM Advanced Communications has a beta of 0.727, meaning that its share price is 27% less volatile than the broader market. Comparatively, Tristel has a beta of 0.34, meaning that its share price is 66% less volatile than the broader market.

Tristel has lower revenue, but higher earnings than BATM Advanced Communications. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BATM Advanced Communications£123.20M0.38-£278.26K-£4.20N/A
Tristel£49.54M3.92£6.54M£16.2424.95

Tristel has a net margin of 15.88% compared to BATM Advanced Communications' net margin of -14.90%. Tristel's return on equity of 23.64% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
BATM Advanced Communications-14.90% -22.13% 0.58%
Tristel 15.88%23.64%9.89%

Summary

Tristel beats BATM Advanced Communications on 11 of the 16 factors compared between the two stocks.

How does BATM Advanced Communications compare to INSPECS Group?

BATM Advanced Communications (LON:BVC) and INSPECS Group (LON:SPEC) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, dividends, institutional ownership, media sentiment, risk and profitability.

16.9% of BATM Advanced Communications shares are owned by institutional investors. Comparatively, 14.8% of INSPECS Group shares are owned by institutional investors. 30.4% of BATM Advanced Communications shares are owned by insiders. Comparatively, 21.0% of INSPECS Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

INSPECS Group has a consensus price target of GBX 60, indicating a potential downside of 28.57%. Given INSPECS Group's higher possible upside, analysts clearly believe INSPECS Group is more favorable than BATM Advanced Communications.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BATM Advanced Communications
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
INSPECS Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

BATM Advanced Communications has higher earnings, but lower revenue than INSPECS Group. INSPECS Group is trading at a lower price-to-earnings ratio than BATM Advanced Communications, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BATM Advanced Communications£123.20M0.38-£278.26K-£4.20N/A
INSPECS Group£191.70M0.45-£4.11M-£8.06N/A

In the previous week, INSPECS Group had 2 more articles in the media than BATM Advanced Communications. MarketBeat recorded 2 mentions for INSPECS Group and 0 mentions for BATM Advanced Communications. BATM Advanced Communications' average media sentiment score of 0.00 beat INSPECS Group's score of -0.23 indicating that BATM Advanced Communications is being referred to more favorably in the media.

Company Overall Sentiment
BATM Advanced Communications Neutral
INSPECS Group Neutral

INSPECS Group has a net margin of -2.67% compared to BATM Advanced Communications' net margin of -14.90%. INSPECS Group's return on equity of -6.07% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
BATM Advanced Communications-14.90% -22.13% 0.58%
INSPECS Group -2.67%-6.07%0.45%

BATM Advanced Communications has a beta of 0.727, meaning that its share price is 27% less volatile than the broader market. Comparatively, INSPECS Group has a beta of 1.674, meaning that its share price is 67% more volatile than the broader market.

Summary

BATM Advanced Communications and INSPECS Group tied by winning 7 of the 14 factors compared between the two stocks.

How does BATM Advanced Communications compare to Akers Biosciences?

BATM Advanced Communications (LON:BVC) and Akers Biosciences (LON:AKR) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, valuation, dividends, profitability and analyst recommendations.

Akers Biosciences has lower revenue, but higher earnings than BATM Advanced Communications. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Akers Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BATM Advanced Communications£123.20M0.38-£278.26K-£4.20N/A
Akers Biosciences£2.32M0.00N/A-£129.60N/A

Given Akers Biosciences' higher probable upside, analysts plainly believe Akers Biosciences is more favorable than BATM Advanced Communications.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BATM Advanced Communications
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Akers Biosciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, BATM Advanced Communications' average media sentiment score of 0.00 equaled Akers Biosciences'average media sentiment score.

Company Overall Sentiment
BATM Advanced Communications Neutral
Akers Biosciences Neutral

16.9% of BATM Advanced Communications shares are owned by institutional investors. 30.4% of BATM Advanced Communications shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Akers Biosciences has a net margin of 0.00% compared to BATM Advanced Communications' net margin of -14.90%. Akers Biosciences' return on equity of 0.00% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
BATM Advanced Communications-14.90% -22.13% 0.58%
Akers Biosciences N/A N/A N/A

Summary

BATM Advanced Communications beats Akers Biosciences on 7 of the 11 factors compared between the two stocks.

How does BATM Advanced Communications compare to Omega Diagnostics Group?

Omega Diagnostics Group (LON:ODX) and BATM Advanced Communications (LON:BVC) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, valuation, dividends, risk, media sentiment and earnings.

Omega Diagnostics Group has a beta of 3.85, meaning that its share price is 285% more volatile than the broader market. Comparatively, BATM Advanced Communications has a beta of 0.727, meaning that its share price is 27% less volatile than the broader market.

In the previous week, Omega Diagnostics Group's average media sentiment score of 0.00 equaled BATM Advanced Communications'average media sentiment score.

Company Overall Sentiment
Omega Diagnostics Group Neutral
BATM Advanced Communications Neutral

29.8% of Omega Diagnostics Group shares are held by institutional investors. Comparatively, 16.9% of BATM Advanced Communications shares are held by institutional investors. 50.6% of Omega Diagnostics Group shares are held by company insiders. Comparatively, 30.4% of BATM Advanced Communications shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Given Omega Diagnostics Group's higher possible upside, research analysts clearly believe Omega Diagnostics Group is more favorable than BATM Advanced Communications.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Omega Diagnostics Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
BATM Advanced Communications
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

BATM Advanced Communications has a net margin of -14.90% compared to Omega Diagnostics Group's net margin of -51.15%. BATM Advanced Communications' return on equity of -22.13% beat Omega Diagnostics Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Omega Diagnostics Group-51.15% -29.14% -10.53%
BATM Advanced Communications -14.90%-22.13%0.58%

BATM Advanced Communications has higher revenue and earnings than Omega Diagnostics Group. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Omega Diagnostics Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Omega Diagnostics Group£7.55M0.00-£3.17M-£0.01N/A
BATM Advanced Communications£123.20M0.38-£278.26K-£4.20N/A

Summary

BATM Advanced Communications beats Omega Diagnostics Group on 8 of the 13 factors compared between the two stocks.

How does BATM Advanced Communications compare to Cambridge Nutritional Sciences?

Cambridge Nutritional Sciences (LON:CNSL) and BATM Advanced Communications (LON:BVC) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.

BATM Advanced Communications has higher revenue and earnings than Cambridge Nutritional Sciences. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Cambridge Nutritional Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cambridge Nutritional Sciences£8.06M0.60-£3.03M£0.603.38
BATM Advanced Communications£123.20M0.38-£278.26K-£4.20N/A

Cambridge Nutritional Sciences has a beta of 2.101, meaning that its share price is 110% more volatile than the broader market. Comparatively, BATM Advanced Communications has a beta of 0.727, meaning that its share price is 27% less volatile than the broader market.

Cambridge Nutritional Sciences has a net margin of 16.94% compared to BATM Advanced Communications' net margin of -14.90%. Cambridge Nutritional Sciences' return on equity of 12.15% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
Cambridge Nutritional Sciences16.94% 12.15% -2.36%
BATM Advanced Communications -14.90%-22.13%0.58%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cambridge Nutritional Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
BATM Advanced Communications
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Cambridge Nutritional Sciences' average media sentiment score of 0.00 equaled BATM Advanced Communications'average media sentiment score.

Company Overall Sentiment
Cambridge Nutritional Sciences Neutral
BATM Advanced Communications Neutral

1.6% of Cambridge Nutritional Sciences shares are owned by institutional investors. Comparatively, 16.9% of BATM Advanced Communications shares are owned by institutional investors. 7.8% of Cambridge Nutritional Sciences shares are owned by company insiders. Comparatively, 30.4% of BATM Advanced Communications shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

BATM Advanced Communications beats Cambridge Nutritional Sciences on 7 of the 13 factors compared between the two stocks.

Get BATM Advanced Communications News Delivered to You Automatically

Sign up to receive the latest news and ratings for BVC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BVC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BVC vs. The Competition

MetricBATM Advanced CommunicationsMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£47.27M£2.79B£6.39B£2.60B
Dividend Yield3.52%2.01%2.81%6.15%
P/E Ratio-3.3116.0520.62365.91
Price / Sales0.3885.08554.1588,030.08
Price / Cash2.12146.5442.4327.89
Price / Book0.602.509.877.74
Net Income-£278.26K£99.80M£3.57B£5.89B
7 Day Performance-6.08%-2.61%0.31%0.21%
1 Month Performance1.46%-1.55%-1.27%1.56%
1 Year Performance-15.24%-12.13%33.54%77.95%

BATM Advanced Communications Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BVC
BATM Advanced Communications
0.5671 of 5 stars
GBX 13.90
-6.1%
N/A-13.1%£47.27M£123.20MN/A980
TSTL
Tristel
1.2669 of 5 stars
GBX 408.90
-1.5%
GBX 400
-2.2%
+2.8%£195.99M£49.54M25.18208
SPEC
INSPECS Group
0.7646 of 5 stars
GBX 84.16
+2.6%
GBX 60
-28.7%
+87.5%£85.57M£195.28MN/A1,673
AKR
Akers Biosciences
N/AN/AN/AN/A£21.64M£2.32MN/A120
ODX
Omega Diagnostics Group
N/AN/AN/AN/A£5.23M£7.55MN/A91

Related Companies and Tools


This page (LON:BVC) was last updated on 5/16/2026 by MarketBeat.com Staff.
From Our Partners